BR100 Increased By (0.16%)
BR30 Increased By (0.03%)
KSE100 Increased By (0.19%)
KSE30 Increased By (0.23%)
AGHA 6.77 Increased By ▲ 0.09 (1.35%)
BECO 4.39 Increased By ▲ 0.02 (0.46%)
BML 57.00 Decreased By ▼ -0.32 (-0.56%)
BOP 30.48 Increased By ▲ 0.13 (0.43%)
CNERGY 13.15 Increased By ▲ 0.03 (0.23%)
CSIL 5.44 Increased By ▲ 0.03 (0.55%)
FCCL 52.96 Increased By ▲ 0.17 (0.32%)
FFL 14.83 Increased By ▲ 0.11 (0.75%)
FNEL 1.13 Increased By ▲ 0.01 (0.89%)
KEL 6.13 Increased By ▲ 0.04 (0.66%)
KOSM 5.85 Increased By ▲ 0.12 (2.09%)
LOTCHEM 26.64 Increased By ▲ 0.18 (0.68%)
MLCF 93.66 Increased By ▲ 0.50 (0.54%)
NBP 165.00 Increased By ▲ 0.34 (0.21%)
NCPL 55.75 Increased By ▲ 0.09 (0.16%)
NPL 61.29 Increased By ▲ 0.13 (0.21%)
OGDC 315.70 Decreased By ▼ -1.03 (-0.33%)
PACE 9.96 Increased By ▲ 0.09 (0.91%)
PAEL 35.70 Increased By ▲ 0.07 (0.2%)
PIBTL 14.98 Increased By ▲ 0.30 (2.04%)
PPL 225.70 Decreased By ▼ -1.21 (-0.53%)
PRL 93.36 Increased By ▲ 0.34 (0.37%)
PTC 60.44 Increased By ▲ 0.18 (0.3%)
SSGC 23.90 Increased By ▲ 0.09 (0.38%)
TBL 8.82 Increased By ▲ 0.07 (0.8%)
TELE 7.86 Increased By ▲ 0.06 (0.77%)
TPL 22.65 Increased By ▲ 0.30 (1.34%)
TPLP 12.97 No Change ▼ 0.00 (0%)
TREET 22.33 Increased By ▲ 0.17 (0.77%)
TRG 56.93 Increased By ▲ 0.37 (0.65%)
By

WASHINGTON: US President Joe Biden said Thursday he would work with Israeli Prime Minister Benjamin Netanyahu, calling the returning right-wing leader his "friend," but vowing to oppose policies that endanger a two-state solution with the Palestinians.

"I look forward to working with Prime Minister Netanyahu, who has been my friend for decades, to jointly address the many challenges and opportunities facing Israel and the Middle East region, including threats from Iran," Biden said in a statement.

Putin welcomes return to power of Israel's Netanyahu: Kremlin

"As we have throughout my administration, the United States will continue to support the two state solution and to oppose policies that endanger its viability or contradict our mutual interests and values."

Comments

Comments are closed for this article.